About this trial
This study collected the clinical, laboratory, and imaging data from patients with intracranial aneurysms, who underwent Pipeline implantation. The purpose of this study is to observe the safety, effcacy, and haemodynamics after Pipeline embolization.
Eligibility criteria
Qualifiers
Aged 22 to 75 years old, male or non-pregnant female;
UIA was diagnosed by CTA, MRA, or DSA;
The size of aneurysms is between 3 to 25mm;
Understands the nature of the procedure and provision of written informed consent;
Disqualifiers
With contraindications to flow-diversion treatment or known allergy to cobalt-chromium alloy or contrast medium;
Pregnancy or lactation;
Coexist with other vascular lesions (coronary artery disease, abdominal aortic aneurysm, severe intracranial artery stenosis, arteriovenous malformation, dural arteriovenous fistula, Moyamoya disease, etc.);
Parent vessel with a diameter <2.0 mm or ≥5.0 mm.;
Trial design
Treatments tested in this trial
- Pipeline embolization device with or without shield technique
Treatment groups
Sponsors and collaborators
Zhujiang Hospital
Lead sponsor
Nanfang Hospital, Southern Medical University
Collaborator
Eighth Affiliated Hospital, Sun Yat-sen University
Collaborator
Zhongshan Hospital Of Traditional Chinese Medicine
Collaborator
First Affiliated Hospital of Jinan University
Collaborator
Beijing Tiantan Hospital
Collaborator
First Affiliated Hospital of Chongqing Medical University
Collaborator
Affiliated Hospital of Southwest Medical University
Collaborator
Guangdong 999 Brain Hospital
Collaborator
Shantou Central Hospital
Collaborator
Guangdong Provincial People's Hospital
Collaborator
The First Affiliated Hospital of Zhengzhou University
Collaborator
First Affiliated Hospital of Harbin Medical University
Collaborator